Back to company

BioTelemetry Technology ApS: Financial statements 2020

CVR: 37552534

BioTelemetry Technology ApS (CVR 37552534) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -124,455 and a net result of DKK -1,137,196 compared with DKK 796,167 the year before. Equity amounted to DKK 15,309,275. The solvency ratio was 52.3%.

Gross Profit
-124,455 kr.
Profit/Loss
-1,137,196 kr.
Equity
15,309,275 kr.
Total Assets
29,274,932 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--124 t.-1.1 mio.15.3 mio.-
2019-412 t.796 t.16.4 mio.0
2018--1 mio.-698 t.15.7 mio.0
2017--2.5 mio.-15.2 mio.16.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BioTelemetry Technology ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

BioTelemetry Technology ApS: The 2019 annual report is outSep 15, 2020

BioTelemetry Technology ApS has published its annual report for 2019. Gross profit came to DKK 411,920, and the net result was DKK 796,167.

About BioTelemetry Technology ApS

BioTelemetry Technology ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2016 and dissolved in 2023. The company was registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The company has 0 employees. In 2022, the company reported a gross profit of DKK -115,998 and a net result of DKK -92,258 compared with DKK -126,560 the year before. Equity amounted to DKK 15,090,457.

Other financial years